Mayne Pharma reported AUD1.24B in Ordinary Share Capital for its second fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Ansell ANN:AU USD 756.8M 13M
Cochlear COH:AU AUD 1.28B 100K
Ecofibre Ltd EOF:AU AUD 115.35M 524K
Healius Ltd HLS:AU AUD 2.42B 2M
Integral Diagnostics Ltd IDX:AU AUD 333.08M 10.54M
Nanosonics Ltd NAN:AU AUD 114.01M 151K
Next Science Ltd NXS:AU USD 113.53M 28.24M
Polynovo Ltd PNV:AU AUD 188.02M 48.59M
Probiotec Ltd PBP:AU AUD 51.66M 367.5K
Ramsay Health Care RHC:AU AUD 2.2B 0
ResMed RMD:AU USD 588K 2K
Sonic Healthcare SHL:AU AUD 3.76B 106.79M
Telix Pharmaceuticals Ltd TLX:AU AUD 370.97M 26.86M